On October 30, 2003, Dimethaid Research Inc. sold by private placement 14,377,688 special warrants for gross proceeds of $14,377,688. On November 26, Dimethaid filed a final prospectus qualifying the distribution of common shares issuable on the exercise of the special warrants. The offering was led by Paradigm Capital Inc., and included Vengate Capital Partners Company.
Dimethaid Research was represented by Torys LLP, with a team that included Michael Pickersgill, Gavin Sinclair and Gary Solway. The agents were represented by Goodman and Carr LLP, with a team that included Jenny Chu Steinberg, Brent Clooney and Jay Goldman.
Dimethaid Research was represented by Torys LLP, with a team that included Michael Pickersgill, Gavin Sinclair and Gary Solway. The agents were represented by Goodman and Carr LLP, with a team that included Jenny Chu Steinberg, Brent Clooney and Jay Goldman.
